col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
Elsevier: Journal of Pharmaceutical Analysis
  original article Date Title Authors   All Authors
1 [GO] 2025―Dec―22 Corrigendum to “Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation” [J. Pharm. Anal. 13 (2023) 11-23] Ningning Wang, Entao Li, Huifang Deng, Lanxin Yue, Lei Zhou, Rina Su, et al. (+6)
2 [GO] 2025―Feb―13 Generation of SARS-CoV-2 dual-target candidate inhibitors through 3D equivariant conditional generative neural networks Zhong-Xing Zhou, Hong-Xing Zhang, Qingchuan Zheng
3 [GO] 2025―Feb―08 Uncovering the covalent inhibitors of SARS-CoV-2 Mpro in Tibetan edible herb Rhodiola crenulata and their synergistic anti-Mpro mechanism Guang-Hao Zhu, Ya-Ni Zhang, Yuan Xiong, Xu-Dong Hou, Qing-Guang Zhang, Zhao-Qin Zhang, et al. (+3)
4 [GO] 2023―Aug―12 Optimization of Nucleic Acid Extraction Methods for Rapid Detection In Pandemic Situations Or Diseases With High Prevalence Hesti Lina Wiraswati, Ilma Fauziah Ma’ruf, Savira Ekawardhani, Lia Faridah, Amila Laelalugina, Harry Septanto, et al. (+3)
5 [GO] 2023―May―22 Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation Yang Yi, Wenzhe Li, Kefang Liu, Heng Xue, Rong Yu, Meng Zhang, et al. (+15)
6 [GO] 2023―Apr―15 Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study Sarfraz Ahmad, Muhammad Usman Mirza, John.F. Trant
7 [GO] 2022―Dec―21 Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265-271] Leonny Dwi Rizkita, Indwiani Astuti
8 [GO] 2022―Nov―02 Advances And Challenges In Using Nirmatrelvir And Its Derivatives Against Sars-Cov-2 Infection Wujun Chen, Bing Liang, Xiaolin Wu, Ling Li, Chao Wang, Dongming Xing
9 [GO] 2022―Oct―27 Evaluation of immunoprotection against coronavirus disease 2019: Novel variants, vaccine inoculation, and complications Congshan Jiang, Kaichong Jiang, Xiaowei Li, Ning Zhang, Wenhua Zhu, Liesu Meng, et al. (+2)
10 [GO] 2022―Oct―22 Inosine: a broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation Ningning Wang, Entao Li, Huifang Deng, Lanxin Yue, Lei Zhou, Rina Su, et al. (+6)
11 [GO] 2022―Jan―04 Machine learning empowered COVID-19 patient monitoring using non-contact sensing: An extensive review Umer Saeed, Syed Yaseen Shah, Jawad Ahmad, Muhammad Ali Imran, Qammer H. Abbasi, Syed Aziz Shah
12 [GO] 2021―Dec―17 Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review Bhagat Singh, Dheer Singh, Vinod Verma, Ramakant Yadav, Raj Kumar
13 [GO] 2021―Nov―10 An outlook on coronavirus disease 2019 detection methods Zahra Hassani Nejad, Fataneh Fatemi, Seyed Ehsan Ranaei Siadat
14 [GO] 2021―Sep―20 Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19 Souparnika H. Manjunath, Rajesh K. Thimmulappa
15 [GO] 2021―Sep―16 Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants Deepa Raghu, Pamela Hamill, Arpitha Banaji, Amy McLaren, Yu-Ting Hsu
16 [GO] 2021―Sep―14 COVID-19 vaccine candidates and vaccine development platforms available worldwide Nilgun Duman, Zahraa ALzaidi, Busra Aynekin, Duygu Taskin, Busra Demirors, Abdulbaki Yildirim, et al. (+6)
17 [GO] 2021―Sep―04 Drug repurposing against coronavirus disease 2019 (COVID-19): A review Lianxiang Luo, Qin Qiu, Fangfang Huang, Kaifeng Liu, Yongqi Lan, Xiaoling Li, et al. (+3)
18 [GO] 2021―Aug―05 Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2 Yury A. Gubarev, Natalya Sh Lebedeva, Elena S. Yurina, Sergey S. Syrbu, Aleksey N. Kiselev, Mikhail A. Lebedev
19 [GO] 2021―Jun―19 Covid-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy Koel Sinha, Sutapa Som Chaudhury, Pramita Sharma, Bhuban Ruidas
20 [GO] 2021―Apr―05 Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules Donata Pluskota-Karwatka, Marcin Hoffmann, Jan Barciszewski
21 [GO] 2021―Mar―27 Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection Congshan Jiang, Xiaowei Li, Changrong Ge, Yuanyuan Ding, Tao Zhang, Shuai Cao, et al. (+2)
22 [GO] 2021―Mar―24 The potential of miRNA-based therapeutics in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a review Leonny Dwi Rizkita, Indwiani Astuti
23 [GO] 2021―Jan―30 Accurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine, serum and saliva samples by GC-MS Süleyman Bodur, Sezin Erarpat, Ömer Tahir Günkara, Sezgin Bakırdere
24 [GO] 2021―Jan―14 Current diagnostic and therapeutic strategies for COVID-19 Bin Bin Chen, Meng Li Liu, Cheng Zhi Huang
25 [GO] 2020―Sep―07 Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2 Chao Liu, Xiaoxiao Zhu, Yiyao Lu, Xianqin Zhang, Xu Jia, Tai Yang
26 [GO] 2020―Aug―28 Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches Mubarak A. Alamri, Muhammad Tahir ul Qamar, Muhammad Usman Mirza, Safar M. Alqahtani, Matheus Froeyen, Ling-Ling Chen
27 [GO] 2020―Jun―26 Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes Natalia Navas, Jesús Hermosilla, Anabel Torrente-López, José Hernández, Jose Cabeza, Raquel Pérez-Robles, Antonio Salmerón-García
28 [GO] 2020―Apr―28 Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase Muhammad Usman Mirza, Matheus Froeyen
29 [GO] 2020―Mar―26 Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants Muhammad Tahir ul Qamar, Safar M. Alqahtani, Mubarak A. Alamri, Ling-Ling Chen
30 [GO] 2020―Mar―09 Molecular immune pathogenesis and diagnosis of COVID-19 Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu
31 [GO] 2020―Mar―06 Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019 Cong Shen, Nan Yu, Shubo Cai, Jie Zhou, Jiexin Sheng, Kang Liu, et al. (+3)
32 [GO] 2020―Mar―01 Recent advances and perspectives of nucleic acid detection for coronavirus Minzhe Shen, Yin Zhou, Jiawei Ye, Abdu Ahmed Abdullah AL-maskri, Yu Kang, Su Zeng, Sheng Cai
 [1] 

32 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec